- ￥250 - 3656
- TargetMol
- T1936
- 2026年07月07日
2 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略：5 种常见类型+关键误区Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- CAS号：
1256580-46-7
- 规格：
1mg/1mLx10mM(inDMSO)/2mg/5mg/10mg/25mg/50mg/100mg/200mg
| 规格： | 1mg | 产品价格： | ￥250.0 |
|---|---|---|---|
| 规格： | 1mLx10mM(inDMSO) | 产品价格： | ￥598.0 |
| 规格： | 2mg | 产品价格： | ￥330.0 |
| 规格： | 5mg | 产品价格： | ￥551.0 |
| 规格： | 10mg | 产品价格： | ￥694.0 |
| 规格： | 25mg | 产品价格： | ￥1112.0 |
| 规格： | 50mg | 产品价格： | ￥1592.0 |
| 规格： | 100mg | 产品价格： | ￥2544.0 |
| 规格： | 200mg | 产品价格： | ￥3656.0 |
Product Introduction
Bioactivity
| 名称 | Alectinib |
| 描述 | Alectinib (RG-7853) is an ALK inhibitor (IC50=1.9 nM, Kd=2.4 nM) that is selective, orally active, and ATP-competitive. Alectinib has antitumor activity and is used in the treatment of non-small cell lung cancer. |
| 细胞实验 | Cells including NSCLC, A549 and HCC827 are seeded in 96-well plates overnight and incubated with various concentrations of CH5424802 for the indicated time. For spheroid cell growth inhibition assay, cells are seeded on spheroid plates, incubated overnight, and then treated with compound for the indicated times. The viable cells are measured by the Luminescent Cell Viability Assay. Caspase-3/7 assay is evaluated using the Caspase-Glo 3/7 Assay Kit.(Only for Reference) |
| 激酶实验 | Kinase inhibitory assays in Vitro: The inhibitory ability against each kinase except for MEK1 and Raf-1 is evaluated by examining their ability to phosphorylate various substrate peptides in the presence of CH5424802 using time-resolved fluorescence resonance energy transfer (TR-FRET) assay or fluorescence polarization (FP) assay. The inhibitory activity against MEK1 is evaluated by quantitative analysis of the phosphorylation of a substrate peptide by a recombinant ERK2 protein in the presence of CH5424802. The inhibitory activity against Raf-1 is evaluated by examining the ability of the kinases to phosphorylate MEK1 in the presence of CH5424802. |
| 体外活性 | 方法：六种神经母细胞瘤 (NB) 细胞系用 Alectinib (0.001-50 µM) 处理 72 h，通过 CCK-8 assay 检测细胞活力。 结果：选择了六种 NB 细胞系，包括三个 ALK-WT 细胞系 (IMR-32、NB-19 和 SK-N-AS) 和三个 ALK 突变细胞系 (Kelly、SH-SY5Y 和 LA-N-6)。Alectinib 处理大大降低了细胞存活率，所测试细胞系的 IC50 范围为 3.181-9.6 µM。[1] 方法：NSCLCA 细胞 NCI-H2228 用 Alectinib (10-1000 nM) 处理 2 h，通过 Western Blot 检测靶点蛋白表达水平。 结果：Alectinib 可以防止表达 EML4-ALK 的 NCI-H2228 NSCLC 细胞中 ALK 的自磷酸化，并且 Alectinib 还导致 STAT3 和 AKT 的磷酸化受到实质性抑制，但 ERK1/2 的磷酸化没有受到实质性的抑制。[2] |
| 体内活性 | 方法：为检测体内抗肿瘤活性，将 Alectinib (25 mg/kg) 腹腔注射给 TH-MYCN 转基因小鼠，每两天一次，给药 11 次。 结果：用 Alectinib 治疗导致 TH-MYCN 转基因小鼠的肿瘤生长减少。Alectinib 在 TH-MYCN 肿瘤组织中诱导 PARP 和 Caspase 3 切割，并阻断 PI3K/Akt/mTOR 信号传导。与 DMSO 治疗相比，Alectinib 暴露延长了 TH-MYCN 转基因小鼠的存活时间。[1] |
| 存储条件 | Keep away from moisture,Keep away from direct sunlight,Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | H2O : 2.1 mM, Sonication is recommended. DMSO : 4.83 mg/mL (10.01 mM), Sonication is recommended. |
| 关键字 | VEGFR2 (KDR) | TyrosineKinases | Tyrosine Kinases | RO-5424802 | RO5424802 | RO 5424802 | RG7853 | RG 7853 | INSR | Inhibitor | inhibit | Cluster of differentiation 246 | CH-5424802 | CH 5424802 | CD246 | Anaplastic lymphoma kinase (ALK) | Anaplastic lymphoma kinase | ALK tyrosine kinase receptor | ALK (R1275Q) | ALK (F1174L) | ALK | Alectinib | AF 802 |
| 相关产品 | Vidarabine | glycine | Gefitinib | Ruxolitinib | Ribociclib | Lenvatinib | Chloramphenicol | Regorafenib | Pazopanib | Sorafenib | Ibrutinib | Nintedanib esylate |
| 相关库 | Inhibitor Library | Bioactive Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | EMA Approved Drug Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | FDA-Approved Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Drug Library |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
官网有文献
技术资料暂无技术资料 索取技术资料
文献支持
艾乐替尼【1256580-46-7】
￥250 - 3656
